동아제약

000640KOSPI

69.5 / 100

Reference Date: 2026-10-23

Financial Score35.0 / 40

News Sentiment12.5 / 25

Momentum8.0 / 20

Disclosure14.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health and PER is significantly undervalued vs. peers is also solid. Slightly down 2.4% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Dong-A Ssosi Holdings operates six business segments, including holding company services, general pharmaceuticals and OTC products, biosimilars and contract manufacturing, logistics, packaging and bottled water, and other sectors like IT solutions and real estate. The general pharmaceuticals segment accounts for approximately 50% of total revenue, with logistics and packaging/bottled water also contributing significantly to sales.

Number of Employees

77people

Average Salary

127.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

6.46Industry Average 15.008.0Point

Half of industry avg (excellent)

PBR

0.53Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

8.26Industry Average 8.004.0Point

In line with industry avg

Debt Ratio

22.03Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20258.0 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲12.5% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲12.9% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 6.4% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (35%)

Current 91,300Won52-week high 119,26552-week low 75,800

1-month return2.0Point

1m -2.35% (slight drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

21 totalPositive 2Neutral 19Negative 0

Neutral결산실적공시예고(안내공시)2026-10-22
Neutral기업설명회(IR)개최(안내공시)2026-10-22
Positive단일판매ㆍ공급계약체결(자회사의 주요경영사항)2026-10-16
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-10-08
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-10-08